AWM
IMGN

Apollon Wealth Management’s Immunogen Inc IMGN Stock Holding History

Apollon Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,000
Closed -$192K – 1000
2023
Q1 		$192K Buy
+50,000
New +$213K 0.01% 798

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Apollon Wealth Management's IMGN Position: Q2 2023 in Review

Apollon Wealth Management sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 50,000 shares — an estimated $192K sold.

Apollon Wealth Management first reported a position in IMGN in Q1 2023 and held it in 1 quarter. The position peaked at $192K in Q1 2023. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Apollon Wealth Management reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Apollon Wealth Management sold 50,000 Immunogen Inc shares in Q2 2023, an estimated $192K.
  • Apollon Wealth Management first reported a position in Immunogen Inc in Q1 2023 and held it in 1 quarter.
  • Apollon Wealth Management's Immunogen Inc position peaked at $192K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Apollon Wealth Management's 13F filing for Q2 2023, filed 4 Aug 2023.